% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Evcman:902559,
author = {Evcüman, Sibel},
title = {{S}ynthese 18{F}-markierter {PET}-{T}racer durch
nukleophile {K}upfer-vermittelte {R}adiofluorierung},
volume = {4430},
school = {Univ. Köln},
type = {Dissertation},
address = {Jülich},
publisher = {Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag},
reportid = {FZJ-2021-04358, 4430},
series = {Berichte des Forschungszentrums Jülich},
pages = {VII, 187},
year = {2021},
note = {Dissertation, Univ. Köln, 2021},
abstract = {Positron emission tomography (PET) enables to detect
physiological and pathophysiological processeson the
cellular or molecular level. Therefore, PET has gained great
importance as a diagnostic imagingtechnique. Thus, a number
of neurological and neoplastic disordes are associated with
alterations inthe expression or activity of certain
receptors, transporters or enzymes, which can be visualized
andquantified using PET imaging. This is achieved by the
application of radiolabeled probes (tracers) thatselectively
interact with a molecular target of interest and can be
detected non-invasively based onthe emission of positrons.
Owing to its favorable half-live and the low energy of
emitted positrons,fluorine-18 is one of the most attractive
radionuclides for labeling of PET-tracers. A number of
noveltransition metal-mediated, late-stage radiofluorination
methods have enabled an easy access to 18Flabeledaromatic
systems regardless of their electronic properties. In
particular, Cu-mediatedradiofluorination with alcohols as
co-solvents has been shown to afford high radiochemical
yields(RCYs) of several clinically relevant PET tracers that
are hardly or not accessible by conventionalmethods.The aim
of the present work was to prepare 18F-labeled PET tracers
for different molecular targets byalcohol-enhanced
Cu-mediated radiofluorination and to evaluate their
properties by preclinicalexperiments in vitro and in vivo.
The molecular targets were selected based on their
pathophysiologicalrelevance and comprised the glycine
transporter 1 (GlyT1), the synaptic vesicle glycoprotein 2A
(SV2A)and the A1 adenosine receptor (A1AR). Following
identification of suitable high-affinity lead structures,the
corresponding precursor compounds were synthesized and
subsequently radiolabeled usingcopper-mediated
radiofluorination.},
cin = {INM-5},
cid = {I:(DE-Juel1)INM-5-20090406},
pnm = {5253 - Neuroimaging (POF4-525)},
pid = {G:(DE-HGF)POF4-5253},
typ = {PUB:(DE-HGF)3 / PUB:(DE-HGF)11},
url = {https://juser.fz-juelich.de/record/902559},
}